Long-term efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B: 5-year results

BACKGROUND AND AIM: Long-term treatment with tenofovir disoproxil fumarate (TDF) has demonstrated suppression of viral replication outside of China. This study aims to assess efficacy, resistance and safety of TDF for up to 240 weeks in Chinese patients with chronic hepatitis B virus (HBV) infection...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hepatol Int
Hlavní autoři: Liang, Xieer, Gao, Zhiliang, Xie, Qing, Zhang, Jiming, Sheng, Jifang, Cheng, Jun, Chen, Chengwei, Mao, Qing, Zhao, Wei, Ren, Hong, Tan, Deming, Niu, Junqi, Chen, Shijun, Pan, Chen, Tang, Hong, Wang, Hao, Mao, Yimin, Jia, Jidong, Ning, Qin, Xu, Min, Wu, Shanming, Li, Jun, Zhang, Xinxin, Zhang, Wenyan, Xiong, Cui, Hou, Jinlin
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer India 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6529393/
https://ncbi.nlm.nih.gov/pubmed/30977033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-019-09943-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky